Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,730 Cr
up ₹84.5 Cr vs Aug 2023
- Stocks held
- 26
- up 1 vs Aug 2023
- Top 10 weight
- 68.1%
- of the portfolio in its ten largest
- Cash & debt
- 1.8%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 12
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In September 2023 it disclosed 26 stocks worth ₹1,730 Cr, up ₹84.5 Cr from Aug 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.6%), Cipla Limited (8.8%), IPCA Laboratories Limited (7.6%); the ten largest together made up 68.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 73.1% of its equity. Cash and debt stood at 1.8%. Compared with Aug 2023 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
28%
Holds more cash than 28% of peers
What these mean: concentration · cash
Holdings in September 2023
Download CSVEvery line the fund disclosed, with the change against Aug 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.65% | down 0.12 pts | ₹236 Cr | up ₹9.6 Cr | Added |
| Cipla Limited | 8.76% | down 1.27 pts | ₹152 Cr | down ₹13.6 Cr | Trimmed |
| IPCA Laboratories Limited | 7.62% | up 1.57 pts | ₹132 Cr | up ₹32.2 Cr | Added |
| Lupin Limited | 7.40% | up 0.11 pts | ₹128 Cr | up ₹8 Cr | Added |
| Suven Pharmaceuticals Limited | 6.82% | up 0.27 pts | ₹118 Cr | up ₹10.2 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.63% | down 0.19 pts | ₹97.5 Cr | up ₹1.7 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.53% | up 0.08 pts | ₹95.7 Cr | up ₹6 Cr | Added |
| Procter & Gamble Health Limited | 4.69% | down 0.01 pts | ₹81.1 Cr | up ₹3.8 Cr | Added |
| Globus Medical Inc | 4.10% | up 2.28 pts | ₹70.9 Cr | up ₹41 Cr | Added |
| Concord Biotech Limited | 3.91% | up 0.22 pts | ₹67.7 Cr | up ₹6.9 Cr | Added |
| Alkem Laboratories Limited | 3.91% | down 0.24 pts | ₹67.7 Cr | down ₹69 L | Trimmed |
| Vijaya Diagnostic Centre Limited | 2.94% | down 0.29 pts | ₹50.9 Cr | down ₹2.2 Cr | Trimmed |
| Zydus Lifesciences Limited | 2.72% | down 0.19 pts | ₹47.1 Cr | down ₹83 L | Trimmed |
| Intuitive Surgical Inc | 2.63% | down 0.31 pts | ₹45.6 Cr | down ₹3 Cr | Trimmed |
| Indoco Remedies Limited | 2.48% | up 0.04 pts | ₹42.8 Cr | up ₹2.7 Cr | Added |
| Aarti Drugs Limited | 2.31% | down 0.25 pts | ₹40 Cr | down ₹2.2 Cr | Trimmed |
| Mankind Pharma Limited | 2.02% | down 0.11 pts | ₹35 Cr | down ₹15 L | Held |
| Cash, TREPS & receivables | 1.83% | down 1.33 pts | ₹31.7 Cr | down ₹20.4 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.83% | down 0.10 pts | ₹31.6 Cr | down ₹10 L | Held |
| Kovai Medical Center and Hospital Limited | 1.73% | down 0.14 pts | ₹29.9 Cr | down ₹89 L | Trimmed |
| Abbott Laboratories | 1.47% | down 0.16 pts | ₹25.4 Cr | down ₹1.5 Cr | Trimmed |
| Unichem Laboratories Limited | 1.44% | up 0.09 pts | ₹24.9 Cr | up ₹2.7 Cr | Added |
| Taro Pharmaceutical Industries Limited | 1.26% | down 0.13 pts | ₹21.8 Cr | down ₹100 L | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.97% | down 0.15 pts | ₹16.8 Cr | down ₹1.7 Cr | Trimmed |
| MedPlus Health Services Limited | 0.85% | down 0.09 pts | ₹14.8 Cr | down ₹82 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.60% | up 0.60 pts | ₹10.4 Cr | up ₹10.4 Cr | New |
| Illumina Inc | 0.55% | down 0.14 pts | ₹9.6 Cr | down ₹1.9 Cr | Trimmed |
| Pfizer Limited | 0.34% | down 0.01 pts | ₹5.9 Cr | up ₹6 L | Added |
What changed, Aug 2023 to Sep 2023
New New positions (1)
- Jupiter Life Line Hospitals Limited0.6% · ₹10.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹41 Cr (+2.28% pts)
- IPCA Laboratories Limitedup ₹32.2 Cr (+1.57% pts)
- Suven Pharmaceuticals Limitedup ₹10.2 Cr (+0.27% pts)
- Sun Pharmaceutical Industries Limitedup ₹9.6 Cr (−0.12% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2023, the weight rose most in Healthcare Equipment & Supplies (+1.9 pts), and fell most in Pharmaceuticals & Biotechnology (−1.5 pts) and Insurance (−0.1 pts).
- Healthcare Equipment & Supplies5.0% → 6.9%+1.9 pts
- Pharmaceuticals & Biotechnology74.6% → 73.1%−1.5 pts
- Insurance2.0% → 1.9%−0.1 pts
- Pharmaceuticals5.7% → 5.5%−0.1 pts
- Retailing1.0% → 0.9%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2020 | Sep 2022 | Mar 2023 | Jun 2023 | Aug 2023 | Sep 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 62.8% | 59.2% | 69.9% | 71.1% | 74.6% | 73.1% |
| Healthcare Services | 21.7% | 25.1% | 15.2% | 13.6% | 11.7% | 11.7% |
| Healthcare Equipment & Supplies | 3.5% | 5.6% | 6.0% | 6.4% | 5.0% | 6.9% |
| Pharmaceuticals | 8.0% | 6.7% | 5.7% | 5.4% | 5.7% | 5.5% |
| Insurance | 4.0% | 2.4% | 2.2% | 2.4% | 2.0% | 1.9% |
| Retailing | — | 1.0% | 1.1% | 1.1% | 1.0% | 0.9% |
Allocation in Sep 2023change vs Aug 2023
- Pharmaceuticals & Biotechnology (14)73.1%▼ 1.5 pts
- Healthcare Services (5)11.7%▼ 0.1 pts
- Healthcare Equipment & Supplies (2)6.9%▲ 1.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2023
1.8%
▼ 1.3 pts vs Aug 2023
- Cash alone
- 1.8%
- cash and net receivables
- A year earlier
- 1.3%
- Sep 2022 · now ▲ 0.5 pts
- Last 12 months
- <0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.